-
Product Insights
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) – Drugs In Development, 2023
Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Drugs In Development, 2023’, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
Alcohol Addiction – Drugs In Development, 2023
Global Markets Direct’s, ‘Alcohol Addiction - Drugs In Development, 2023’, provides an overview of the Alcohol Addiction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alcohol Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chemotherapy Induced Peripheral Neuropathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy Induced Peripheral Neuropathy - Drugs In Development, 2023’, provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Peripheral Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Chemotherapy Induced Neutropenia – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Drugs In Development, 2023’, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Neutropenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Radiation Injury – Drugs In Development, 2023
Global Markets Direct’s, ‘Radiation Injury - Drugs In Development, 2023’, provides an overview of the Radiation Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Radiation Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chemotherapy Induced Anemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Drugs In Development, 2023’, provides an overview of the Chemotherapy Induced Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Anemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Acute Opioid Overdosage – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Opioid Overdosage - Drugs In Development, 2023’, provides an overview of the Acute Opioid Overdosage pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Opioid Overdosage, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Chemotherapy Induced Oral Mucositis – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy Induced Oral Mucositis - Drugs In Development, 2023’, provides an overview of the Chemotherapy Induced Oral Mucositis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Oral Mucositis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Chemotherapy-Induced Diarrhea (CID) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy-Induced Diarrhea (CID) - Drugs In Development, 2023’, provides an overview of the Chemotherapy-Induced Diarrhea (CID) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy-Induced Diarrhea (CID), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Gastrointestinal Radiation Toxicity – Drugs In Development, 2023
Global Markets Direct’s, ‘Gastrointestinal Radiation Toxicity - Drugs In Development, 2023’, provides an overview of the Gastrointestinal Radiation Toxicity pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastrointestinal Radiation Toxicity, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...